In Great Britain, the vaccine produced by the Pfizer-BioNTech company against coronavirus will be used in children from 6 months to 4 years old.

APA reports that the UK Medicines and Health Products Regulatory Organization has released information about this.

The organization said that the vaccine meets the required safety, quality and efficacy standards.

Before the decision, tests were conducted among 4526 volunteers.